SCHEMBL8916983

SCHEMBL8916983

CNc1nc(C)c(C(=O)OC)c(-c2cccc(Cl)c2Cl)c1C#N

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.46
▸ HTT P42858 3/20 0.46
▸ HSD17B10 Q99714 1/20 0.46
▸ ALOX15 P16050 1/20 0.40
▸ GAA P10253 2/20 0.40
▸ LMNA P02545 2/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ HPGD P15428 4/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ SLC6A3 Q01959 1/20 0.38
▸ KDM4E B2RXH2 4/20 0.37
▸ POLB P06746 1/20 0.37
▸ NUDT1 P36639 1/20 0.36
▸ PLA2G2A P14555 1/20 0.36
▸ NPSR1 Q6W5P4 2/20 0.36
▸ MAPT P10636 2/20 0.36
▸ PTPN11 Q06124 1/20 0.35
▸ ABCG2 Q9UNQ0 1/20 0.35
▸ CRHBP P24387 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8917183 0.87 ALDH1A1 (0.54) ALDH1A1HTTHSD17B10GAALMNA
SCHEMBL8976107 0.83 ALDH1A1 (0.42) ALDH1A1HTTHSD17B10ALOX15SMN1; SMN2
SCHEMBL8917875 0.80 MAPT (0.40) ALDH1A1HTTGAALMNASMN1; SMN2
SCHEMBL13410042 0.78 GAA (0.47) ALDH1A1HTTGAALMNASMN1; SMN2
SCHEMBL6951228 0.77 SMN1; SMN2 (0.49) ALDH1A1HTTGAALMNASMN1; SMN2
SCHEMBL30587182 0.77 SMN1; SMN2 (0.49) ALDH1A1HTTGAALMNASMN1; SMN2
SCHEMBL6949718 0.75 GAA (0.56) ALDH1A1HTTHSD17B10GAALMNA
SCHEMBL31231118 0.75 GAA (0.56) ALDH1A1HTTHSD17B10GAALMNA
SCHEMBL30686655 0.75 GAA (0.56) ALDH1A1HTTHSD17B10GAALMNA
SCHEMBL10747419 0.73 GAA (0.44) ALDH1A1HTTGAALMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5670525-A Substituted 4-phenyl-6-amino-nicotinic acid compounds useful in the treatment of CNS disorders BAYER AKTIENGESELLSCHAFT (DE) 1997-09-23 — — US disclosed
Send feedback